Development of an optimized conditionally replicative adenoviral agent for ovarian cancer.
Zhu ZB, Lu B, Park M, Makhija SK, Numnum TM, Kendrick JE, Wang M, Tsuruta Y, Fisher P, Alvarez RD, Zhou F, Siegal GP, Wu H, Curiel DT.
Zhu ZB, et al. Among authors: kendrick je.
Int J Oncol. 2008 Jun;32(6):1179-88. doi: 10.3892/ijo_32_6_1179.
Int J Oncol. 2008.
PMID: 18497979